Subcutaneous implantable cardioverter-defibrillator and defibrillation testing: A propensity-matched pilot study
Authors:
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Heart Rhythm
- Vol. 18 (12) , 2072-2079
Abstract
No abstract availableKeywords
Funding Information
- Boston Scientific Corporation
This publication has 18 references indexed in Scilit:
- Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United StatesJAMA Cardiology, 2016
- 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testingHeart Rhythm, 2016
- Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trialEuropean Heart Journal, 2015
- Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE)The Lancet, 2015
- Is Defibrillation Testing Necessary for Implantable Transvenous Defibrillators?Circulation: Arrhythmia and Electrophysiology, 2014
- Defibrillation TestingJACC, 2012
- Defibrillation threshold testing fails to show clinical benefit during long-term follow-up of patients undergoing cardiac resynchronization therapy defibrillator implantationEP Europace, 2011
- Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: a nation-wide surveyEP Europace, 2007
- On the mechanism of the probabilistic nature of ventricular defibrillation thresholdAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Efficacy and Temporal Stability of Reduced Safety Margins for Ventricular DefibrillationCirculation, 2002